// App-Quantinova.ai

P190 : Poor mental health risk is associated with high disease activity in axial spondyloarthritis in the UK: results from the International Map of Axial Spondyloarthritis (IMAS)

Researchers

Presenter

  • Marco Garrido-Cumbrera

Principal Investigators

  • Laura Christen

  • Jose Correa-Fernandez

  • Jill Hamilton

  • Helena Marzo-Ortega

Medical Centers

  • Health & Territory Research, Universidad de Sevilla, Seville, Spain, Sevilla

  • Patient Engagement, Novartis Pharma AG, Basel, Switzerland

  • Leeds Teaching Hospitals NHS Trust and NIHR Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom

  • Head of Policy & Health Services, National Axial Spondyloarthritis Society (NASS), London, United Kingdom

Locations

  • Spain

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Central Nervous System (CNS)

Disease

  • Axial spondyloarthritis

  • Depression

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved